Return to Faculty List

Faculty

Nino Marzella

Associate Professor of Pharmacy Practice Clinical Pharmacy Specialist - NYHHCS Brooklyn Campus

B.S., LIU BrooklynPharm.D., LIU BrooklynM.S., LIU Brooklyn

Specialties

Areas of specialty include critical care (medical intensive care) and infectious diseases pharmacotherapy.

Publications

Limited Circulation Publications

  • Semple E, Marzella N. Maximizing your final year of pharmacy school: navigating the landscape of APPEs. Royals Counties New York Society of Health System Pharmacists. Volume 3 Issue 2 APRIL 2023.
  • Willner D, Kaluza K, Marzella N. The same tenofovir but a “TAD” different. New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 24: page 2 Winter 2017. (In print)
  • Davidovitis C, Patel N, Tohme S, et al. Erectile Dysfunction. New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 23: page 10 Spring 2016. (In print)
  • Chew S, Mathew A, Neve S, et al. PrEP: A special type of protection. New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 22: pages 7-8 Winter 2016. (In print)
  • Lee A, Kuruvilla N, Sessa J, et al. Glucose-6-Phosphate Dehydrogenase Deficiency. New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 22: page 9-10 Winter 2016. (In print)
  • Yaloumis M, Korobova N, Patel Y, Marzella N. Innovative antimicrobial Avycaz® (ceftazidime-avibactam). New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 21: Summer 2015. (In print)
  • Rothberger N, Askarinam L, Akhand T, Marzella N. Pseudobulbar Affect (PBA): Role of Neudexta® New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 18: Fall 2014. (In print)
  • Sivkov A, Marzella N. Procalcitonin – A marker for infection? New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 7: September/October 2012. (In print)
  • Rosner D, Koslowsky A, Marzella N. Azithromycin – Risk of Cardiovascular Death. New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 6: July/August 2012. (In print)
  • Scarlino L, Marzella N. Roflumilast (Daliresp®). New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 2: November/December 2011. (In print)
  • Shmayenik A, Marzella N. Fidaxomicin (Dificid®). New York Harbor Healthcare System Clinical Pharmacy Newsletter, Volume 1; Issue 2: November/December 2011. (In print)
  • Morris K, Marezlla N. Xolair (Omalizumab) Update. New York Harbor Healthcare System Clinical Pharmacy Newsletter. August 2003.
  • Ziso J, Marzella N. What is HIPAA? New York Harbor Healthcare System Clinical Pharmacy Newsletter. June 2003.
  • George DC, Marzella N. Tequin (Gatifloxacin) Update. New York Harbor Healthcare System Clinical Pharmacy Newsletter. March 2003.
  • Marzella N, Martin AE. What is the interaction between occasional alcohol consumption and warfarin therapy? Drug Information Forum: New York Harbor Clinical Pharmacy Newsletter,
  • Marzella N, Martin AE. Can I prescribe an angiotensin receptor blocker (ARB) in a patient who has experienced angioedema on an ACE inhibitor (ACE-I)? Drug Information Forum: New York Harbor Clinical Pharmacy Newsletter, February 2002.
  • Marzella N. Statins and the Cytochrome P-450 system. New York Harbor Clinical Pharmacy Newsletter, November 2001.
  • Marzella N. Nesiritide. National VA Pharmacy Benefits Management Monograph, October 2001.
  • Marzella N. The drug interaction between ubiquinone and warfarin. New York Methodist Newsletter, January 2001.

Peer Reviewed Journals

  • Marzella N.Treatment for Multidrug Resistant Gram-Negative Infections With Cefiderocol (Fetroja), The Journal for Nurse Practitioners,Volume 19, Issue 3, 2023, 104518, ISSN 1555-4155, https://doi.org/10.1016/j.nurpra.2022.11.026.
  • Quattrocchi E, Goldberg T, Marzella N. (2020) Management of type 2 diabetes: consensus of diabetes organizations. Drugs in Context. 9: 212607.
  • Wu PB, Chung E, Marzella N, Preis J. (2019) Streptococcus gordonii perihepatic abscess: A case report. Am J Clin Microbiol Antimicrob. 2(2): 1038.
  • Patel Y, Marzella N. A dietary supplement-drug interaction-induced serotonin syndrome progresses to acute compartment syndrome. Am J Case Reports. 2017; 18:926-930 (In print)
  • Lee y, Lim WI, Bloom CI, et al. Bezlotoxumab Zinplava® for Clostridium difficile infection: The first monoclonal antibody approved to prevent the recurrence of a bacterial infection. Pharmacy and Therapeutics (P&T) December 2017. Volume 42; Number 12, pages 735-738. (In print)
  • Montgomery M, Ho N, Chung E, Marzella N. Daclatasvir (Daklinza®) A treatment option for chronic hepatitis C infection. Pharmacy and Therapeutics (P&T) December 2016. Volume 41; Number 12, pages 751-755. (In print)
  • Lonie JM, Marzella N, Perry R, Shah B, Jariwala J. Pharmacists Levels of Emotionality and career success correlates: an exploratory study. J Pharm Pract 2015 Jun; 28(3): 256-60. (In print)
  • Sorbera M, Chung E, Ho CW, Marzella N. Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections. Pharmacy and Therapeutics P & T 2014 Dec; 39(12): 825-32. (In print)
  • Rattu MA, Shah N, Lee JM, Pham AQ, Marzella N. Glucarpidase (Voraxaze), a Carboxypeptidase Enzyme for Methotrexate Toxicity. Pharmacy and Therapeutics P & T. Dec 2013; 38(12): 732, 741-744. (In print)
  • Rattu MA, Shah N, Marzella N. The Role of Pharmacists in Tetanus Management and Prevention: US Pharm. 2013; 38 (5): 39-52. (In print)
  • Rattu MA, Shah N, Singhal S, Marzella N. The Role of Pharmacists in the Management of Acute Kidney Stones. US Pharm. 2013; 38 (8): HS4-HS8. (In print)
  • Rivkin A, Yin H, Borno L, Fabbio K, Kugler A, Maltz FN, Marzella N, Mehta M, Najib JW. Revising senior pharmacy grand rounds to incorporate longitudinal board review to prepare students for licensing examination. Currents in Pharmacy Teaching and Learning Volume 5, Issue 3, Pages 236–240, May–June 2013. (In print)
  • Plotkin P, Patel K, Uminski A, Marzella N. Telavancin (Vibativ), a new option for the treatment of gram- positive infections. Pharmacy and Therapeutics P & T. March 2011; 36 (3): pages 127-128, 133-138. (In print)
  • Emerson CR, Marzella N. Dexlansporazole: a proton pump inhibitor with dual delayed release system. Clinical Therapeutics. August 2010; 32(9): pages 1578- 1596. (In print)
  • Hubulashvili D, Marzella N. NPLATE® Romiplostim: a novel treatment option for immune (Idiopathic) thrombocytopenic purpura. Pharmacy and Therapeutics P&T. September 2009. Volume 34; Number 9 pages 482 - 485. (In print)
  • Cocchio C, Marzella N. Cinryze® - Human plasma derived C1 esterase inhibitor for prophylaxis of hereditary angioedema. Pharmacy and Therapeutics P&T. June 2009. Volume 34; Number 6. Pages 293 - 295. (In print)
  • Emerson CR, Bercume C, Marzella N, Antonopolous MS. The Use of t-PA (Activase®) for the Treatment of an Empyema in an Adult Patient. The Journal of Pharmacy Practice. February 2009. Volume 22; Number 1. Pages 117-123. (In print)
  • Emerson CR, Antonopolous MS, Marzella N, Grossman S. Economic Impact of Implementing Pneumonia Treatment Guidelines for Intravenous to Oral Conversion. Hospital Pharmacy. November 2008. Volume 43; Number 11. pages 886 – 894. (In print)
  • Emerson CR, Marzella N. Ramoplanin: A Promising New Treatment for Clostridium difficile - Associated Diarrhea and Vancomycin-resistant Enterococcus. Pharmacy and Therapeutics. October 2007. Volume 32; Number 10. pages 535 – 543.
  • Abrams P, Marzella N. Dabigatran (Rendix®): A Promising New Oral Direct Thrombin Inhibitor. Pharmacy and Therapeutics. May 2007. Volume 32; Number 5. pages 271 – 5.
  • Student leaders warn: professionalism, not plagiarism. Doses and Notices. November 2006: Volume 9; Number 1. Page 1 and continued on 8. Written by Jimmy Demico and Angie Davanos; Edited submission
  • Marzella N. Baraclude® For treatment of chronic Hepatitis B Virus (HBV) infection. P & T. June 2006; 31 (6) 313 – 320.
  • Marzella N, Kourlas H. Chronic obstructive pulmonary disease (COPD) a review and update. New York State Journal of Health System-Pharmacy. NYJHP.24; (6) 7 – 16.
  • Marzella N, Antonopoulos MS. Sculptra®: A novel treatment approach for HIV – associated facial lipoatrophy. Pharmacy and Therapeutics. April 2005; 30 (4) 206 – 14.
  • Hilas O, Marzella N. Ximelagatran (Exanta®): A product review and update. Pharmacy and Therapeutics.
  • February 2005; 30 (2) 92 – 95.
  • Stone EA, Marzella N. Infectious diseases: what every pharmacist needs to know. A focus on SARS and WNV. NYJHP. July – August 2004; 8 – 19. (0.2 CEU for completion of post exam)
  • Hilas O, Marzella N. FluMist®: A live attenuated influenza vaccine. Pharmacy and Therapeutics. 2004; 29 (2) 84 – 88.
  • Emerson CR, Antonopoulos MS, Marzella N, Grossman SS. “Evaluating the Pharmacologic Treatment of Pneumonia at the Department of Veterans Affairs New York Healthcare System.” Presented at the annual ASHP Midyear Clinical Meeting. Anaheim, CA. December 2006.
  • Kourlas H, Martin AE, Marzella N. “Implementation of a Pharmacist – Managed Amiodarone Monitoring Clinic in the Department of Veterans Administration Medical Center.” American College of Clinical Pharmacy Program and Abstracts, Palms Springs, CA. April 2003.
  • Marzella N, Reilly JP, Bini E. “The quality of life in patients with gastroesophageal reflux disease (GERD) and proton pump inhibitors.” Presented at Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore MD. April 2002.
  • Marzella N. Evaluating the use of Tamsulosin in a Veterans population. Presented at the ASHP Mid-Year Clinical Meeting Poster Presentation, New Orleans, LA. December 2001.


Lectures and Presentations

  • Rattu MA, Marzella N, et al. , “Effects of chronic oral proton pump inhibitor therapy on serum magnesium and calcium levels at a Veterans Affairs Medical Center.”, Eastern States Conference, 2013
  • Rattu MA, Marzella N, Mast A, et al. , “Evaluation of chronic oral phenytoin therapy and its effects on serum calcium and vitamin D levels at a Veterans Affairs Medical Center.”, Poster 7-145). ASHP 2012 Midyear Clinical Meeting. Las Vegas, Nevada., 2012
  • Billedo J, Chung E, Ho C, Marzella N.., “Evaluation of triglyceride management in patients on antiretroviral therapy at New York Harbor Healthcare System.”, Eastern States Conference, Hershey, Pennsylvania., 2012

Honors/Awards

Recipient for the LIU Pharmacy Faculty Preceptor of the Year Award 2023 & 2020

Professional Affiliations

American Society of Health System Pharmacists (ASHP)
American Pharmaceutical Association (APhA)
American College of Clinical Pharmacy (ACCP)
American Association of Colleges of Pharmacy (AACP)
Honorary Inductee into the Phi-Lambda Sigma Pharmacy Leadership Society – Beta Kappa Chapter